If you’re managing Reference Listed Drug (RLD) updates manually, it might feel like a routine regulatory task. Check updates. Compare documents. Implement changes. Simple enough — until something gets missed. And that’s the real problem. Because in pharma compliance, even a small miss in an RLD update isn’t just an error — it’s a risk that can impact your entire regulatory standing. Why RLD Tracking Demands More Than a Manual Process A Reference […]
You already know how critical Reference Listed Drug (RLD) updates are for your regulatory compliance. But here’s the real question — how long can you continue managing them manually without risking errors, delays, or compliance gaps? Because as your product portfolio grows and updates become more frequent, manual tracking doesn’t just slow you down — it starts exposing your process to […]
If you’re working in regulatory affairs, you’ve definitely come across the term Reference Listed Drug (RLD). But here’s the real question — are you just familiar with the term, or do you actually understand how deeply it impacts your compliance, documentation, and daily workflow? Because in reality, RLD isn’t just a reference — it’s the foundation of your regulatory alignment. What is a […]
In pharmaceutical development, regulatory documentation is not simply an administrative task. It is a critical step that directly impacts approval timelines. When you are responsible for preparing DMF (Drug Master File) and drug product submissions, every section must be scientifically accurate, internally consistent, and aligned with regulatory expectations. Preparing a complete dossier often takes several months and, in many cases, close […]
If you’re responsible for regulatory renewals, 2026 is not business as usual. Health authorities across the globe are no longer just accepting electronic submissions — they are actively enforcing precision, structure, and lifecycle discipline. When your product licence is on the line, renewal submissions must be more than complete; they must be technically flawless, audit-ready, and digitally optimised from day one. Regulators such as the U.S. FDA, […]
How to Successfully Update Your Dossier: A Guide to Post-Approval Variations So, you’ve got the Marketing Authorisation (MA) for your medicinal product! But, let’s be real, it’s not a one-and-done deal. As your product’s lifecycle progresses, you’ll need to make updates to its dossier to ensure it remains compliant with regulatory requirements. What’s a Variation, Anyway? A variation is any change to a medicinal product’s registered dossier, decision granting MA, Summary of Product Characteristics, Package Leaflet, […]
As the pharmaceutical industry increasingly adopts the electronic Common Technical Document (eCTD) as a global submission standard, Non-eCTD electronic Submissions (NeeS) continue to hold relevance in certain regions. Regulatory affairs professionals managing multi-region dossiers must understand where NeeS remains accepted, what limitations it presents, and how to plan an adaptable submission strategy accordingly. This blog explores why NeeS still exists, which markets continue to support […]
In today’s global pharmaceutical landscape, regulatory submissions must meet highly structured standards—and those standards are rapidly evolving. As more countries transition from paper-based Common Technical Documents (CTD) to fully digital electronic CTD (eCTD) formats, companies are under increasing pressure to stay compliant across all regions. Understanding which authorities require or accept CTD or eCTD is […]
How an eCTD Software Solution Simplifies Regulatory Submissions Pharmaceutical regulatory submissions have evolved from paper-based chaos to highly structured electronic formats. The electronic Common Technical Document (eCTD) has become the global standard for submitting dossiers to agencies like the USFDA, EMA, Health Canada, PMDA, and others. But with stringent formatting rules, metadata tagging, version control, […]
Pharmaceutical companies planning to market their products internationally must navigate a complex web of regulatory submission requirements. While many regions follow the ICH Common Technical Document (CTD) or its electronic version (eCTD), each regulatory authority has its own specifications, processes, and expectations. Understanding these differences is essential for regulatory affairs professionals to avoid delays, technical […]